Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.
Identifieur interne : 001787 ( PubMed/Corpus ); précédent : 001786; suivant : 001788Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.
Auteurs : Aeron C. Hurt ; David S. Hui ; Alan Hay ; Frederick G. HaydenSource :
- Influenza and other respiratory viruses [ 1750-2659 ] ; 2015.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Communicable Diseases, Emerging, Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Humans, Immunocompromised Host, Influenza Vaccines, Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Middle East Respiratory Syndrome Coronavirus, Pandemics, Respiratory Syncytial Virus Infections (drug therapy), Respiratory Syncytial Virus Infections (epidemiology), Respiratory Tract Infections (drug therapy), Respiratory Tract Infections (epidemiology), Respiratory Tract Infections (prevention & control), Respiratory Tract Infections (virology), Virus Diseases (drug therapy), Virus Diseases (epidemiology), Virus Diseases (virology).
- MESH :
- chemical , therapeutic use : Antiviral Agents.
- drug therapy : Coronavirus Infections, Influenza, Human, Respiratory Syncytial Virus Infections, Respiratory Tract Infections, Virus Diseases.
- epidemiology : Coronavirus Infections, Influenza, Human, Respiratory Syncytial Virus Infections, Respiratory Tract Infections, Virus Diseases.
- prevention & control : Influenza, Human, Respiratory Tract Infections.
- virology : Influenza, Human, Respiratory Tract Infections, Virus Diseases.
- Communicable Diseases, Emerging, Humans, Immunocompromised Host, Influenza Vaccines, Middle East Respiratory Syndrome Coronavirus, Pandemics.
Abstract
This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.
DOI: 10.1111/irv.12293
PubMed: 25399715
Links to Exploration step
pubmed:25399715Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.</title><author><name sortKey="Hurt, Aeron C" sort="Hurt, Aeron C" uniqKey="Hurt A" first="Aeron C" last="Hurt">Aeron C. Hurt</name><affiliation><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL at the Peter Doherty Institute for Infection and Immunity, Parkville, Vic., Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Vic., Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Hui, David S" sort="Hui, David S" uniqKey="Hui D" first="David S" last="Hui">David S. Hui</name></author><author><name sortKey="Hay, Alan" sort="Hay, Alan" uniqKey="Hay A" first="Alan" last="Hay">Alan Hay</name></author><author><name sortKey="Hayden, Frederick G" sort="Hayden, Frederick G" uniqKey="Hayden F" first="Frederick G" last="Hayden">Frederick G. Hayden</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25399715</idno><idno type="pmid">25399715</idno><idno type="doi">10.1111/irv.12293</idno><idno type="wicri:Area/PubMed/Corpus">001787</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001787</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.</title><author><name sortKey="Hurt, Aeron C" sort="Hurt, Aeron C" uniqKey="Hurt A" first="Aeron C" last="Hurt">Aeron C. Hurt</name><affiliation><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL at the Peter Doherty Institute for Infection and Immunity, Parkville, Vic., Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Vic., Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Hui, David S" sort="Hui, David S" uniqKey="Hui D" first="David S" last="Hui">David S. Hui</name></author><author><name sortKey="Hay, Alan" sort="Hay, Alan" uniqKey="Hay A" first="Alan" last="Hay">Alan Hay</name></author><author><name sortKey="Hayden, Frederick G" sort="Hayden, Frederick G" uniqKey="Hayden F" first="Frederick G" last="Hayden">Frederick G. Hayden</name></author></analytic><series><title level="j">Influenza and other respiratory viruses</title><idno type="eISSN">1750-2659</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>Communicable Diseases, Emerging</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (epidemiology)</term><term>Humans</term><term>Immunocompromised Host</term><term>Influenza Vaccines</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (virology)</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Pandemics</term><term>Respiratory Syncytial Virus Infections (drug therapy)</term><term>Respiratory Syncytial Virus Infections (epidemiology)</term><term>Respiratory Tract Infections (drug therapy)</term><term>Respiratory Tract Infections (epidemiology)</term><term>Respiratory Tract Infections (prevention & control)</term><term>Respiratory Tract Infections (virology)</term><term>Virus Diseases (drug therapy)</term><term>Virus Diseases (epidemiology)</term><term>Virus Diseases (virology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Influenza, Human</term><term>Respiratory Syncytial Virus Infections</term><term>Respiratory Tract Infections</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Influenza, Human</term><term>Respiratory Syncytial Virus Infections</term><term>Respiratory Tract Infections</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term><term>Respiratory Tract Infections</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Communicable Diseases, Emerging</term><term>Humans</term><term>Immunocompromised Host</term><term>Influenza Vaccines</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Pandemics</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25399715</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.</ArticleTitle><Pagination><MedlinePgn>20-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12293</ELocationID><Abstract><AbstractText>This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted. </AbstractText><CopyrightInformation>© 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hurt</LastName><ForeName>Aeron C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL at the Peter Doherty Institute for Infection and Immunity, Parkville, Vic., Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hui</LastName><ForeName>David S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>Frederick G</ForeName><Initials>FG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antivirals</Keyword><Keyword MajorTopicYN="N">clinical management</Keyword><Keyword MajorTopicYN="N">immunocompromised</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">respiratory</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25399715</ArticleId><ArticleId IdType="doi">10.1111/irv.12293</ArticleId><ArticleId IdType="pmc">PMC4280814</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Antimicrob Chemother. 2014 Sep;69(9):2458-69</Citation><ArticleIdList><ArticleId IdType="pubmed">24840623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2013;4:1935</Citation><ArticleIdList><ArticleId IdType="pubmed">23736803</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Sep 26;369(13):1227-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24066743</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Jun 1;50(11):1493-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20415572</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2014;19(6). pii: 20701</Citation><ArticleIdList><ArticleId IdType="pubmed">24556348</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2012 Nov;206(9):1359-66</Citation><ArticleIdList><ArticleId IdType="pubmed">22927451</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2014 Apr;10(4):e1004065</Citation><ArticleIdList><ArticleId IdType="pubmed">24699865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2010 Aug;10(8):521-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20620116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2012 Jan;47(1):88-94</Citation><ArticleIdList><ArticleId IdType="pubmed">21358686</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2013 Oct;57(8):1069-77</Citation><ArticleIdList><ArticleId IdType="pubmed">23876395</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 Jun 29;381(9885):2273-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23726392</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2012 Dec 15;206(12):1872-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23033148</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2004 Dec;31(4):304-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15494274</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2013;6:CD004878</Citation><ArticleIdList><ArticleId IdType="pubmed">23733383</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):583-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15248091</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Jun 10;301(22):2362-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19509383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2010 Oct;29(10):898-904</Citation><ArticleIdList><ArticleId IdType="pubmed">20442686</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2011 Mar;62(3):232-3</Citation><ArticleIdList><ArticleId IdType="pubmed">21237199</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2012 May;18(5):731-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21963623</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Chemother. 2011 Oct;17(5):595-601</Citation><ArticleIdList><ArticleId IdType="pubmed">21850418</ArticleId></ArticleIdList></Reference><Reference><Citation>MBio. 2014;5(2):e00884-14</Citation><ArticleIdList><ArticleId IdType="pubmed">24570370</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Jan 15;44(2):197-202</Citation><ArticleIdList><ArticleId IdType="pubmed">17173216</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Infect Dis. 2011 Aug;24(4):333-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21666460</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1:63-75</Citation><ArticleIdList><ArticleId IdType="pubmed">23279899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Jul;14(7):609-18</Citation><ArticleIdList><ArticleId IdType="pubmed">24852376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Chemother. 2013 Aug;19(4):740-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23732307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2014 Feb 22;383(9918):714-21</Citation><ArticleIdList><ArticleId IdType="pubmed">24507376</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Virol. 2013 Nov;8(11):1085-1094</Citation><ArticleIdList><ArticleId IdType="pubmed">24563658</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2014 Jul 15;190(2):145-54</Citation><ArticleIdList><ArticleId IdType="pubmed">24937476</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2014 Aug 1;210(3):435-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24569063</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7 Suppl 3:52-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24215382</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Jun 13;368(24):2277-85</Citation><ArticleIdList><ArticleId IdType="pubmed">23697469</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2013 Nov;57(10):i; discussion i</Citation><ArticleIdList><ArticleId IdType="pubmed">24014736</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1998 Sep;102(3 Pt 1):531-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9738173</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2014 Dec 15;210(12):1900-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24951824</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2011 May 12;117(19):5050-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21372154</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2013 Jun 5;309(21):2223-31</Citation><ArticleIdList><ArticleId IdType="pubmed">23695200</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2008 Mar;27(3):282-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18342750</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2015 Jan 1;211(1):80-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25030060</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2014 May;58(5):2718-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24566185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2014 Feb 8;383(9916):541-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24183056</ArticleId></ArticleIdList></Reference><Reference><Citation>Transpl Infect Dis. 2010 Dec;12(6):513-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21062390</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 May;15(5):756-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19402962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76</Citation><ArticleIdList><ArticleId IdType="pubmed">23210147</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Jan;14(1):50-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24239323</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24733924</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2010 Oct 15;202(8):1154-60</Citation><ArticleIdList><ArticleId IdType="pubmed">20831384</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014;9(3):e91630</Citation><ArticleIdList><ArticleId IdType="pubmed">24667532</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2011 Feb 15;183(4):531-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20851929</ArticleId></ArticleIdList></Reference><Reference><Citation>J Obstet Gynaecol Res. 2012 May;38(5):757-62</Citation><ArticleIdList><ArticleId IdType="pubmed">22487092</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2014 Jul;8(4):452-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24702710</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2014 Jan;69(1):32-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24025442</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Ther. 2013;18(3):377-86</Citation><ArticleIdList><ArticleId IdType="pubmed">23264438</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2014 Mar;8(2):151-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23953886</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2012 Dec 15;206(12):1844-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23045618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2005 Aug;51(2):98-102</Citation><ArticleIdList><ArticleId IdType="pubmed">16038758</ArticleId></ArticleIdList></Reference><Reference><Citation>Transpl Infect Dis. 2013 Oct;15(5):487-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23890293</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2014 Oct;110:94-103</Citation><ArticleIdList><ArticleId IdType="pubmed">25108173</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2008 Aug 1;47(3):339-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18582202</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Jan 17;358(3):261-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18199865</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2014 Jul;33(7):703-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24356256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Jul 25;499(7459):500-3</Citation><ArticleIdList><ArticleId IdType="pubmed">23823727</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Jan;58(2):214-24</Citation><ArticleIdList><ArticleId IdType="pubmed">24186906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2014 May;2(5):395-404</Citation><ArticleIdList><ArticleId IdType="pubmed">24815805</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 Dec 29;365(26):2541-2</Citation><ArticleIdList><ArticleId IdType="pubmed">22204735</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Jun 13;368(24):2339-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23718151</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2013 Dec;67(6):606-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24096239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2013;3:3058</Citation><ArticleIdList><ArticleId IdType="pubmed">24162312</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2011 Jul;17(7):979-86</Citation><ArticleIdList><ArticleId IdType="pubmed">20870025</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2013;4:2854</Citation><ArticleIdList><ArticleId IdType="pubmed">24326875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S177-83, discussion S182</Citation><ArticleIdList><ArticleId IdType="pubmed">16378043</ArticleId></ArticleIdList></Reference><Reference><Citation>Transpl Infect Dis. 2014 Feb;16(1):141-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24383501</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2012 Jul 15;206(2):148-57</Citation><ArticleIdList><ArticleId IdType="pubmed">22561367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 May 1;375(9725):1545-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20399493</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014;9(3):e92822</Citation><ArticleIdList><ArticleId IdType="pubmed">24671139</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2014 Aug;44(2):535-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24696114</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2014 Jan;52(1):288-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24131685</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(1):e29971</Citation><ArticleIdList><ArticleId IdType="pubmed">22238686</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2014;19(1). pii: 20666</Citation><ArticleIdList><ArticleId IdType="pubmed">24434172</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2011 Apr;30(4):284-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21048522</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 May 9;368(19):1791-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23656644</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2012 May;93(Pt 5):980-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22258859</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001787 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001787 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25399715
|texte= Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25399715" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |